Gene study aims to predict chemo side effects in leukemia patients

NCT ID NCT06580106

First seen Feb 02, 2026 · Last updated May 14, 2026 · Updated 15 times

Summary

This study explores how a person's genetic makeup influences side effects and response to two common leukemia drugs (azacitidine and venetoclax). Researchers will enroll 50 adults newly diagnosed with acute myeloid leukemia (AML) and track side effects like infections and low blood counts. The goal is to better understand why some patients have more severe reactions, which could help personalize treatment in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA, MYELOID, ACUTE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Levine Cancer Institute

    RECRUITING

    Charlotte, North Carolina, 28204, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Wake Forest Baptist Comprehensive Cancer Center

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.